Eloxx Pharmaceuticals, Inc. reports

Company location: Arlington, MA
Fiscal year end: 31 December

Eloxx Pharmaceuticals, Inc. has filed 1,349 SEC EDGAR filings since 27 Mar 1997

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 176-200 of 916 matching filings.

Per page

25

Current page

8

8-K File 001-31326

FORM 8-K

Filing date: 20 May 2021
Reporting date: 19 May 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 18 May 2021
Reporting date: 18 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 18 May 2021
Reporting date: 18 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-31326

FORM 8-K

Filing date: 18 May 2021
Reporting date: 18 May 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-31326

FORM 8-K

Filing date: 18 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B5 File 333-228430

424B5

Filing date: 17 May 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 17 May 2021
Reporting date: 13 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-228430

424B5

Filing date: 13 May 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-31326

10-Q

Filing date: 07 May 2021
Reporting date: 31 Mar 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-31326

FORM 8-K

Filing date: 07 May 2021
Reporting date: 06 May 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 03 May 2021
Reporting date: 30 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-31326

FORM 8-K

Filing date: 29 Apr 2021
Reporting date: 29 Apr 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 22 Apr 2021
Reporting date: 20 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-31326

FORM 8-K

Filing date: 20 Apr 2021
Reporting date: 20 Apr 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13D File 005-56243

FORM SC 13D

Filing date: 13 Apr 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 05 Apr 2021
Reporting date: 01 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 05 Apr 2021
Reporting date: 01 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 02 Apr 2021
Reporting date: 01 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Apr 2021
Reporting date: 01 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 02 Apr 2021
Reporting date: 01 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Apr 2021
Reporting date: 01 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Apr 2021
Reporting date: 01 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .